E-Z-EM Congratulates the 2005 Isadore N. Stern Scholarship Recipients.

LAKE SUCCESS, N.Y. -- E-Z-EM, Inc., (NASDAQ:EZEM) today announced that the American Society of Radiologic Technologists (ASRT) Education and Research Foundation has selected the Isadore N. Stern Scholarship recipients for 2005. Funded by E-Z-EM Inc., the scholarship is available for ASRT members who are continuing their education. The scholarship honors Isadore Stern, the father of E-Z-EM co-founder, director and Chairman Emeritus Howard S. Stern. The 2005 Isadore N. Stern Scholarship recipients are:

--Cheryl DuBose of Warner Robins, GA, enrolled in a Master's of Science in Radiologic Sciences Degree program at Midwestern State University in Wichita Falls, Texas.

--Jo Ellen Hagemeyer of Crooks, SD, enrolled in a Bachelor of Science in Healthcare Management degree program at Bellevue University in Bellevue, Nebraska.

--Brandi Huber of Coralville, IA, enrolled in a Nuclear Medicine Certificate Program at the University of Iowa in Iowa City.

--Therese Krug of Oakdale, MN, enrolled in a Health Arts Bachelor's Degree program at the University of St. Francis in Joliet, Illinois.

--Joan Lucas of Wauwatosa, WI, enrolled in a Bachelor of Science in Radiologic Technology Degree program at Marian College in Fond Du Lac.

--Kristi Lutjelusche of Aurora, CO, enrolled in a Bachelor of Radiologic Sciences Degree program at Florida Hospital College of Health Sciences in Orlando.

--Barbara McIntyre of Boca Raton, FL, enrolled in a dual Master's of Business Administration/Master's of Health Administration Degree program at Florida Atlantic University.

--Wendy Moore of Robersonville, NC, enrolled in a Bachelor of Science in Radiologic Sciences Degree program at Midwestern State University in Wichita Falls, Texas.

--Sheri Thayer of Colrain, MA, enrolled in a Bachelor of Radiologic Sciences Degree program at the University of Massachusetts, Amherst.

Commenting on the announcement, Joseph Palma, Sr. Vice President of North American Imaging Sales and National Accounts for E-Z-EM, said, "This scholarship was designed to reward students for their outstanding professional commitment to the radiologic sciences, and we at E-Z-EM are delighted to be able to support this important educational program. All of us at E-Z-EM offer our congratulations to this year's recipients."

About E-Z-EM, Inc.

E-Z-EM is a leading manufacturer of contrast agents for gastrointestinal radiology. The Company recently introduced VoLumen(R) the next generation low-density barium sulfate suspension for use as an oral contrast in Multidetector CT (MDCT) and PET/CT studies. The Company also offers Empower(R) -- the only family of CT injectors on the market with patented EDA(TM) technology that can help detect contrast extravasation -- and offers a complete product set for the virtual colonoscopy practitioner. This product line consists of virtual colonoscopy hardware, software, nutritional prep kits and bowel cleaners, tagging agents and a carbon dioxide colon insufflation system.

The statements made in this document contain certain forward-looking statements. Words such as "expects," "intends," "anticipates," "plans," "believes," "seeks," "estimates" or variations of such words and similar expressions, are intended to identify such forward-looking statements. The forward-looking statements contained in this release may involve numerous risks and uncertainties, known and unknown, beyond the Company's control. Such risks and uncertainties include the ability of the Company to develop its products, the results of ongoing medical research for, market acceptance and future sales of VoLumen, future actions by the FDA or other regulatory agencies, overall economic conditions, general market conditions, foreign currency exchange rate fluctuations as well as the risk factors listed from time to time in the SEC filings of E-Z-EM, Inc., including but not limited to its Form 10-Q for the quarter ended February 26, 2005 and its Annual Report on Form 10-K for the fiscal year ended May 29, 2004. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements, and investors are cautioned not to place undue reliance on the forward-looking statements included in this release.